Effects of fluoxetine hydrochloride on depressive symptoms and P300 after cerebral stroke

Chinese Journal of Clinical Rehabilitation

Volumn 10, Issue 14, 2006, Pages 160-162

  Song, Jing Gui ^a   Zhang, Zhao Hui ^a   Wang, Xia Hong ^a   Mu, Jun Lin ^a  

^a Department of Neurology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; FLUOXETINE; PSYCHOTROPIC AGENT;

ADULT; AMPLITUDE MODULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; CHINA; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG DOSE REGIMEN; EMOTION; EVENT RELATED POTENTIAL; FEMALE; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SPIKE WAVE; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; UNIVERSITY HOSPITAL;

EID: 33747322815     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Liu YZ, Long J. Status quo on epidemiologic study of post-stroke depression. Guowai Yixue: Naoxueguan Jibing Fence 2000;8(6):340
2. Bhogal SK, Teasell R, Foley N, et al. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke 2004;35(3):794-802
3. Zhang MY. Manual of Psycho-rating Scales. Changsha: Hunan Technological Publishing House 1993:34-7
4. King RB, Shade-Zeldow Y, Carlson CE, et al. Adaptation to stroke: a longitudinal study of depressive symptoms, physical health, and coping process. Top Stroke Rehabil 2002;9(1):46-66
5. Spalletta G, Caltagirone C. Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms. Funct Neurol 2003;18(4):227-32
6. Dam H. Depression in stroke patients 7 years following stroke. Acta Psychiatr Scand 2001;103(4):187-93
7. Liu SD, Song M. Treatment of fluoxetine on 48 cases post-stroke depression patients. Zuzhong yu Shenjing Jibing 2002;9(4):208
8. Polich J, Herbst KL. P300 as a clinical assay: rationale, evaluation, and findings. Int J Psychophysiol 2000;38(1):3-19
9. Hansenne M. The p300 cognitive event-related potential. I. Theoretical and psychobiologic perspectives. Neurophysiol Clin 2000;30(4):191-210
10. Frodl T, Meisenzahl EM, Muller D, et al. P300 subcomponents and clinical symptoms in schizophrenia. Int J Psychophysiol 2002;43(3):237-46
11. Zhang MD, Chen XS. Brain Evoked Potential Science. Shanghai: Shanghai Technological Publishing House 1995:256-68